메뉴 건너뛰기




Volumn 174, Issue 5, 2014, Pages 732-739

Expression of HLA class i antigen, aspirin use, and survival after a diagnosis of colon cancer

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; HLA ANTIGEN CLASS 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 2; UNCLASSIFIED DRUG;

EID: 84897978063     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.511     Document Type: Article
Times cited : (93)

References (36)
  • 1
    • 84860467522 scopus 로고    scopus 로고
    • Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials
    • Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13(5):518-527.
    • (2012) Lancet Oncol. , vol.13 , Issue.5 , pp. 518-527
    • Algra, A.M.1    Rothwell, P.M.2
  • 2
    • 68849123400 scopus 로고    scopus 로고
    • Aspirin use and survival after diagnosis of colorectal cancer
    • Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649-658.
    • (2009) JAMA , vol.302 , Issue.6 , pp. 649-658
    • Chan, A.T.1    Ogino, S.2    Fuchs, C.S.3
  • 4
    • 84874938572 scopus 로고    scopus 로고
    • Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
    • McCowan C, Munro AJ, Donnan PT, Steele RJ. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. Eur J Cancer. 2013;49(5):1049-1057.
    • (2013) Eur J Cancer. , vol.49 , Issue.5 , pp. 1049-1057
    • McCowan, C.1    Munro, A.J.2    Donnan, P.T.3    Steele, R.J.4
  • 5
    • 78650215449 scopus 로고    scopus 로고
    • Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
    • Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741-1750.
    • (2010) Lancet. , vol.376 , Issue.9754 , pp. 1741-1750
    • Rothwell, P.M.1    Wilson, M.2    Elwin, C.E.3
  • 6
    • 78650825618 scopus 로고    scopus 로고
    • Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials
    • Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31-41.
    • (2011) Lancet. , vol.377 , Issue.9759 , pp. 31-41
    • Rothwell, P.M.1    Fowkes, F.G.2    Belch, J.F.3    Ogawa, H.4    Warlow, C.P.5    Meade, T.W.6
  • 7
    • 84863399038 scopus 로고    scopus 로고
    • Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
    • Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379(9826):1591-1601.
    • (2012) Lancet. , vol.379 , Issue.9826 , pp. 1591-1601
    • Rothwell, P.M.1    Wilson, M.2    Price, J.F.3    Belch, J.F.4    Meade, T.W.5    Mehta, Z.6
  • 8
    • 84860250352 scopus 로고    scopus 로고
    • Use of aspirin postdiagnosis improves survival for colon cancer patients
    • Bastiaannet E, Sampieri K, Dekkers OM, et al. Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer. 2012;106(9):1564-1570.
    • (2012) Br J Cancer. , vol.106 , Issue.9 , pp. 1564-1570
    • Bastiaannet, E.1    Sampieri, K.2    Dekkers, O.M.3
  • 9
    • 84867101876 scopus 로고    scopus 로고
    • Aspirin as adjuvant therapy for colorectal cancer - Reinterpreting paradigms
    • Chia WK, Ali R, Toh HC. Aspirin as adjuvant therapy for colorectal cancer - reinterpreting paradigms. Nat Rev Clin Oncol. 2012;9(10):561-570.
    • (2012) Nat Rev Clin Oncol. , vol.9 , Issue.10 , pp. 561-570
    • Chia, W.K.1    Ali, R.2    Toh, H.C.3
  • 10
    • 84871027434 scopus 로고    scopus 로고
    • Aspirin use after diagnosis improves survival in older adults with colon cancer: A retrospective cohort study
    • ReimersMS, Bastiaannet E, van Herk-Sukel MP, et al. Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study. J AmGeriatr Soc. 2012;60(12):2232-2236.
    • (2012) J AmGeriatr Soc. , vol.60 , Issue.12 , pp. 2232-2236
    • Reimers, M.S.1    Bastiaannet, E.2    Van Herk-Sukel, M.P.3
  • 11
    • 20144388469 scopus 로고    scopus 로고
    • Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis
    • DongM, Johnson M, Rezaie A, et al. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis. Clin Cancer Res. 2005;11(6):2265-2271.
    • (2005) Clin Cancer Res. , vol.11 , Issue.6 , pp. 2265-2271
    • Dong, M.1    Johnson, M.2    Rezaie, A.3
  • 12
    • 11144224065 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer
    • Soumaoro LT, Uetake H, Higuchi T, Takagi Y, EnomotoM, Sugihara K. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res. 2004;10(24):8465-8471.
    • (2004) Clin Cancer Res. , vol.10 , Issue.24 , pp. 8465-8471
    • Soumaoro, L.T.1    Uetake, H.2    Higuchi, T.3    Takagi, Y.4    Enomoto, M.5    Sugihara, K.6
  • 15
    • 0020692577 scopus 로고
    • Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
    • FitzGerald GA, Oates JA, Hawiger J, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983;71(3):676-688.
    • (1983) J Clin Invest. , vol.71 , Issue.3 , pp. 676-688
    • Fitzgerald, G.A.1    Oates, J.A.2    Hawiger, J.3
  • 16
    • 0019988413 scopus 로고
    • Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
    • Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982;69(6):1366-1372.
    • (1982) J Clin Invest. , vol.69 , Issue.6 , pp. 1366-1372
    • Patrignani, P.1    Filabozzi, P.2    Patrono, C.3
  • 17
    • 84867817838 scopus 로고    scopus 로고
    • Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival
    • Liao X, Lochhead P, Nishihara R, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012;367(17):1596-1606.
    • (2012) N Engl J Med. , vol.367 , Issue.17 , pp. 1596-1606
    • Liao, X.1    Lochhead, P.2    Nishihara, R.3
  • 18
    • 81255205399 scopus 로고    scopus 로고
    • Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
    • Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576-590.
    • (2011) Cancer Cell. , vol.20 , Issue.5 , pp. 576-590
    • Labelle, M.1    Begum, S.2    Hynes, R.O.3
  • 19
    • 84855893130 scopus 로고    scopus 로고
    • Platelet-derived MHC class i confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells
    • Placke T, Örgel M, SchallerM, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72(2):440-448.
    • (2012) Cancer Res. , vol.72 , Issue.2 , pp. 440-448
    • Placke, T.1    Örgel, M.2    Schaller, M.3
  • 20
    • 76749138150 scopus 로고    scopus 로고
    • The predictive value of HLA class i tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer
    • de Kruijf EM, van Nes JG, Sajet A, et al. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin Cancer Res. 2010;16(4):1272-1280.
    • (2010) Clin Cancer Res. , vol.16 , Issue.4 , pp. 1272-1280
    • De Kruijf, E.M.1    Van Nes, J.G.2    Sajet, A.3
  • 21
    • 34247270377 scopus 로고    scopus 로고
    • HLA expression and cancer - 14th IHIWS immunohistochemistry quality control exercise exchange results
    • Chew SF, Kanaan C, Tait BD. HLA expression and cancer - 14th IHIWS immunohistochemistry quality control exercise exchange results. Tissue Antigens. 2007;69(suppl 1):248-251.
    • (2007) Tissue Antigens. , vol.69 , Issue.SUPPL. 1 , pp. 248-251
    • Chew, S.F.1    Kanaan, C.2    Tait, B.D.3
  • 22
    • 0036083347 scopus 로고    scopus 로고
    • Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus
    • Buskens CJ, Van Rees BP, Sivula A, et al. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology. 2002;122(7):1800-1807.
    • (2002) Gastroenterology. , vol.122 , Issue.7 , pp. 1800-1807
    • Buskens, C.J.1    Van Rees, B.P.2    Sivula, A.3
  • 23
    • 10744232899 scopus 로고    scopus 로고
    • Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer
    • de Jong AE, van Puijenbroek M, Hendriks Y, et al.Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10(3):972-980.
    • (2004) Clin Cancer Res. , vol.10 , Issue.3 , pp. 972-980
    • De Jong, A.E.1    Van Puijenbroek, M.2    Hendriks, Y.3
  • 24
    • 24144493178 scopus 로고    scopus 로고
    • Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome
    • Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer. 2005;4(3):255-265.
    • (2005) Fam Cancer. , vol.4 , Issue.3 , pp. 255-265
    • Baudhuin, L.M.1    Burgart, L.J.2    Leontovich, O.3    Thibodeau, S.N.4
  • 25
    • 84870956218 scopus 로고    scopus 로고
    • Assessment of a fully automated high-throughput DNA extractionmethod from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis
    • van Eijk R, Stevens L, Morreau H, vanWezel T. Assessment of a fully automated high-throughput DNA extractionmethod from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis. Exp Mol Pathol. 2013;94(1):121-125.
    • (2013) Exp Mol Pathol. , vol.94 , Issue.1 , pp. 121-125
    • Van Eijk, R.1    Stevens, L.2    Morreau, H.3    Vanwezel, T.4
  • 26
    • 79952381358 scopus 로고    scopus 로고
    • Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR
    • van Eijk R, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One. 2011;6(3):e17791.
    • (2011) PLoS One. , vol.6 , Issue.3
    • Van Eijk, R.1    Licht, J.2    Schrumpf, M.3
  • 27
  • 28
    • 27944441722 scopus 로고    scopus 로고
    • Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class i expression correlates with a poor prognosis
    • Watson NF, Ramage JM, Madjd Z, et al. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer. 2006;118(1):6-10.
    • (2006) Int J Cancer. , vol.118 , Issue.1 , pp. 6-10
    • Watson, N.F.1    Ramage, J.M.2    Madjd, Z.3
  • 29
    • 84866156209 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma
    • Al-Maghrabi J, Buhmeida A, Emam E, et al. Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.World J Gastroenterol. 2012;18(15):1793-1799.
    • (2012) World J Gastroenterol , vol.18 , Issue.15 , pp. 1793-1799
    • Al-Maghrabi, J.1    Buhmeida, A.2    Emam, E.3
  • 30
    • 84859840481 scopus 로고    scopus 로고
    • PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
    • Fariña Sarasqueta A, Zeestraten EC, vanWezel T, et al. PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis. Cell Oncol (Dordr). 2011;34(6):523-531.
    • (2011) Cell Oncol (Dordr). , vol.34 , Issue.6 , pp. 523-531
    • Fariña Sarasqueta, A.1    Zeestraten, E.C.2    Vanwezel, T.3
  • 31
    • 84892843686 scopus 로고    scopus 로고
    • Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer
    • Domingo E, Church DN, Sieber O, et al. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. J Clin Oncol. 2013;31(34):4297-4305.
    • (2013) J Clin Oncol. , vol.31 , Issue.34 , pp. 4297-4305
    • Domingo, E.1    Church, D.N.2    Sieber, O.3
  • 32
    • 84876954094 scopus 로고    scopus 로고
    • Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis
    • Akalay I, Janji B, HasmimM, et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 2013;73(8):2418-2427.
    • (2013) Cancer Res. , vol.73 , Issue.8 , pp. 2418-2427
    • Akalay, I.1    Janji, B.2    Hasmim, M.3
  • 33
    • 82955212867 scopus 로고    scopus 로고
    • COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
    • HolmesMD, ChenWY, Schnitt SJ, et al. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011;130(2):657-662.
    • (2011) Breast Cancer Res Treat. , vol.130 , Issue.2 , pp. 657-662
    • Holmes, M.D.1    Chen, W.Y.2    Schnitt, S.J.3
  • 34
    • 84885183806 scopus 로고    scopus 로고
    • Low-dose aspirin use and cancer characteristics: A population-based cohort study
    • Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y. Low-dose aspirin use and cancer characteristics: a population-based cohort study. Br J Cancer. 2013;109(7):1921-1925.
    • (2013) Br J Cancer. , vol.109 , Issue.7 , pp. 1921-1925
    • Jonsson, F.1    Yin, L.2    Lundholm, C.3    Smedby, K.E.4    Czene, K.5    Pawitan, Y.6
  • 35
    • 84879395305 scopus 로고    scopus 로고
    • Aspirin use and risk of colorectal cancer according to BRAF mutation status
    • Nishihara R, Lochhead P, Kuchiba A, et al. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA. 2013;309(24): 2563-2571.
    • (2013) JAMA , vol.309 , Issue.24 , pp. 2563-2571
    • Nishihara, R.1    Lochhead, P.2    Kuchiba, A.3
  • 36
    • 34548781961 scopus 로고    scopus 로고
    • Using prescription claims data for drugs available over-the-counter (OTC)
    • Yood MU, Campbell UB, Rothman KJ, et al. Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf. 2007;16(9):961-968.
    • (2007) Pharmacoepidemiol Drug Saf. , vol.16 , Issue.9 , pp. 961-968
    • Yood, M.U.1    Campbell, U.B.2    Rothman, K.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.